BlackRock LifePath® Index 2060 Fund Institutional Shares
LIZIX
NASDAQ
Weiss Ratings | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Good | |||
Risk Grade | B- | |||
Company Info | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | BlackRock | |||
Manager/Tenure (Years) | Christopher Chung (5), Michael Pensky (0), Peter Tsang (0) | |||
Website | http://www.blackrock.com | |||
Fund Information | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | BlackRock LifePath® Index 2060 Fund Institutional Shares | |||
Category | Target-Date 2060 | |||
Sub-Category | Target Date | |||
Prospectus Objective | Asset Allocation | |||
Inception Date | Feb 29, 2016 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 2,000,000.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 1.69% | |||
Dividend | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 2.08% | |||
Asset Allocation | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 3.38% | |||
Stock | 94.58% | |||
U.S. Stock | 56.74% | |||
Non-U.S. Stock | 37.84% | |||
Bond | 1.00% | |||
U.S. Bond | 0.84% | |||
Non-U.S. Bond | 0.16% | |||
Preferred | 0.01% | |||
Convertible | 0.00% | |||
Other Net | 1.04% | |||
Price History | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 1.14% | |||
30-Day Total Return | 3.90% | |||
60-Day Total Return | 8.30% | |||
90-Day Total Return | 6.94% | |||
Year to Date Total Return | 18.60% | |||
1-Year Total Return | 17.91% | |||
2-Year Total Return | 54.60% | |||
3-Year Total Return | 83.99% | |||
5-Year Total Return | 86.19% | |||
Price | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $25.57 | |||
1-Month Low NAV | $24.45 | |||
1-Month High NAV | $25.57 | |||
52-Week Low NAV | $18.95 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $25.57 | |||
52-Week High Price (Date) | Oct 01, 2025 | |||
Beta / Standard Deviation | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.92 | |||
Standard Deviation | 13.03 | |||
Balance Sheet | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 4.78B | |||
Operating Ratios | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.14% | |||
Turnover Ratio | 12.00% | |||
Performance | LIZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 16.01% | |||
Last Bear Market Total Return | -15.18% | |||